Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can cure patients with high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). However, many patients relapse or develop debilitating graft-versus-host disease. Transplant restores T-cell reactivity agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Andrea, Goodman, Aaron M., Rane, Zachary, Talwar, James V., Frampton, Garrett M., Morris, Gerald P., Lippman, Scott M., Zhang, Xinlian, Kurzrock, Razelle, Carter, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448732/
https://www.ncbi.nlm.nih.gov/pubmed/37637234
http://dx.doi.org/10.36401/JIPO-22-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448732/
https://www.ncbi.nlm.nih.gov/pubmed/37637234
http://dx.doi.org/10.36401/JIPO-22-19

Ejemplares similares